CAY10575 (Synonyms: IKK2 Inhibitor 3, Polo-like Kinase Inhibitor 1) |
Katalog-Nr.GC43176 |
CAY10575 (Verbindung 8) ist ein IKK2-Inhibitor mit einem IC50 von 0,075 μM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 916985-21-2
Sample solution is provided at 25 µL, 10mM.
The NF-κB/Rel transcription factors, known to be involved in the regulation of pro-inflammatory cytokines and the pathogenesis of a variety of diseases, are present in the cytosol in an inactive state, complexed with inhibitory IκB proteins. NF-κB is activated upon degradation of IκB following IKK-α and IKK-β phosphorylation. IKK-ε, a homolog of IKK-α and IKK-β, can also activate NF-κB. IKK-ε is expressed predominantly in immune cells and is thought to play a role in the immune response. CAY10575 is a benzimidazole analog that inhibits IKK-ε with an IC50 value of ~15.8 µM.
Average Rating: 5
(Based on Reviews and 7 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *